Focal immune-mediated white matter demyelination reveals an age-associated increase in axonal vulnerability and decreased remyelination efficiency.

In addition to being an established risk factor for neurodegenerative diseases, age is increasingly recognized as adversely influencing regeneration. Accumulating evidence also suggests that age plays important, although poorly understood, roles with respect to course and prognosis in the degenerative and untreatable later phase of multiple sclerosis. Two experimental models of multiple sclerosis have been particularly influential in modeling the different aspects of neuronal injury and regeneration: global experimental autoimmune encephalomyelitis and focal toxin-mediated injury. Against this background, we report a focal model of immune-mediated demyelinating injury that reliably generates targeted primary demyelination and axonal injury. A detailed pathologic characterization of this model, modified extensively from an earlier study, showed that aged adult animals exhibited increased vulnerability to axonal injury and reduced efficiency of remyelination compared with younger animals. More important, remyelination in aged animals was predominantly Schwann cell mediated, in contrast to the central oligodendrocyte-mediated remyelination that predominated in younger rodents. Together, these findings establish an experimental platform to further study the influence of age on injury and repair in a biologically relevant model of human demyelinating injury.

[1]  R. Franklin,et al.  Demyelination and remyelination of the caudal cerebellar peduncle of adult rats following stereotaxic injections of lysolecithin, ethidium bromide, and complement/anti‐galactocerebroside: A comparative study , 1999, Glia.

[2]  F. Mokhtarian,et al.  Prevention of axonal injury using calpain inhibitor in chronic progressive experimental autoimmune encephalomyelitis , 2008, Brain Research.

[3]  Hans Lassmann,et al.  Remyelination is extensive in a subset of multiple sclerosis patients. , 2006, Brain : a journal of neurology.

[4]  C. Raine,et al.  Glial bridges and Schwann cell migration during chronic demyelination in the C.N.S. , 1978, Journal of neurocytology.

[5]  M. Schumacher,et al.  Systemic progesterone administration results in a partial reversal of the age‐associated decline in CNS remyelination following toxin‐induced demyelination in male rats , 2004, Neuropathology and applied neurobiology.

[6]  H. Weiner,et al.  Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis. , 2008, The Journal of clinical investigation.

[7]  W. Young,et al.  Central axons in injured cat spinal cord recover electrophysiological function following remyelination by Schwann cells , 1989, Journal of the Neurological Sciences.

[8]  R. Franklin,et al.  Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency , 2008, Nature Neuroscience.

[9]  Toru Yamamoto,et al.  Extensive proliferation of peripheral type myelin in necrotic spinal cord lesions of multiple sclerosis , 1991, Journal of the Neurological Sciences.

[10]  J. Fawcett,et al.  A potential role for bone morphogenetic protein signalling in glial cell fate determination following adult central nervous system injury in vivo , 2007, The European journal of neuroscience.

[11]  Chao Zhao,et al.  The Age-Related Decrease in CNS Remyelination Efficiency Is Attributable to an Impairment of Both Oligodendrocyte Progenitor Recruitment and Differentiation , 2002, The Journal of Neuroscience.

[12]  W. F. Blakemore,et al.  Age increases axon loss associated with primary demyelination in cuprizone-induced demyelination in C57BL/6 mice , 2006, Journal of Neuroimmunology.

[13]  M. Peschanski,et al.  Demyelination, and remyelination by Schwann cells and oligodendrocytes after kainate-induced neuronal depletion in the central nervous system , 1992, Neuroscience.

[14]  I. Duncan,et al.  Schwann cell invasion of the central nervous system of the myelin mutants , 1997, Journal of anatomy.

[15]  A. Hirano,et al.  Remyelination in multiple sclerosis with peripheral type myelin. , 1973, Archives of neurology.

[16]  R. Franklin,et al.  Delayed Changes in Growth Factor Gene Expression during Slow Remyelination in the CNS of Aged Rats , 2000, Molecular and Cellular Neuroscience.

[17]  W. Brück,et al.  Remyelination capacity of the MS brain decreases with disease chronicity , 2009, Neurology.

[18]  S. Vukusic,et al.  Age at disability milestones in multiple sclerosis. , 2006, Brain : a journal of neurology.

[19]  In Koo Hwang,et al.  Comparison of Ionized Calcium-binding Adapter Molecule 1-Immunoreactive Microglia in the Spinal Cord Between Young Adult and Aged Dogs , 2010, Neurochemical Research.

[20]  M. Schwab,et al.  Targeting experimental autoimmune encephalomyelitis lesions to a predetermined axonal tract system allows for refined behavioral testing in an animal model of multiple sclerosis. , 2004, The American journal of pathology.

[21]  Y. Nakazato,et al.  Neuromyelitis optica with intraspinal expansion of Schwann cell remyelination , 2009, Neuropathology : official journal of the Japanese Society of Neuropathology.

[22]  S. Whittemore,et al.  Schwann cell‐like differentiation by adult oligodendrocyte precursor cells following engraftment into the demyelinated spinal cord is BMP‐dependent , 2006, Glia.

[23]  R. Franklin,et al.  Taking ageing into account in remyelination-based therapies for multiple sclerosis , 2008, Journal of the Neurological Sciences.

[24]  D. Rowitch,et al.  CNS-resident glial progenitor/stem cells produce Schwann cells as well as oligodendrocytes during repair of CNS demyelination. , 2010, Cell stem cell.

[25]  Remyelination in multiple sclerosis , 1979, Annals of neurology.

[26]  J. Fawcett,et al.  An experimental model of secondary progressive multiple sclerosis that shows regional variation in gliosis, remyelination, axonal and neuronal loss , 2008, Journal of Neuroimmunology.

[27]  R. Franklin,et al.  Remyelination occurs as extensively but more slowly in old rats compared to young rats following gliotoxin‐induced CNS demyelination , 1999, Glia.

[28]  Maria Liguori,et al.  Age‐related disability in multiple sclerosis , 2002, Annals of neurology.

[29]  C. Constantinescu,et al.  Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS) , 2011, British journal of pharmacology.

[30]  Chao Zhao,et al.  Differences in the early inflammatory responses to toxin-induced demyelination are associated with the age-related decline in CNS remyelination , 2006, Neurobiology of Aging.

[31]  L. Hayflick How and why we age , 1994, Experimental Gerontology.

[32]  Kenneth J. Smith,et al.  Inflammation and primary demyelination induced by the intraspinal injection of lipopolysaccharide , 2005, Brain : a journal of neurology.

[33]  K. Irvine,et al.  Remyelination protects axons from demyelination-associated axon degeneration. , 2008, Brain : a journal of neurology.

[34]  W. Brück,et al.  A new focal EAE model of cortical demyelination: multiple sclerosis-like lesions with rapid resolution of inflammation and extensive remyelination. , 2006, Brain : a journal of neurology.

[35]  Michael Hutchinson,et al.  New perspectives in the natural history of multiple sclerosis , 2010, Neurology.

[36]  Y. Itoyama,et al.  Schwann cell remyelination of demyelinated axons in spinal cord multiple sclerosis lesions , 1983, Annals of neurology.

[37]  Robin J. M. Franklin,et al.  Remyelination in the CNS: from biology to therapy , 2008, Nature Reviews Neuroscience.

[38]  I. Griffiths,et al.  Nerve fibres in spinal cord impact injuries Part 1. Changes in the myelin sheath during the initial 5 weeks , 1983, Journal of the Neurological Sciences.

[39]  N. Rooijen,et al.  Increased intrinsic neuronal vulnerability and decreased beneficial reaction of macrophages on axonal regeneration in aged rats , 2010, Neurobiology of Aging.

[40]  V. Bohr,et al.  DNA repair, mitochondria, and neurodegeneration , 2007, Neuroscience.

[41]  W. Blakemore Remyelination by Schwann cells of axons demyelinated by intraspinal injection of 6-aminonicotinamide in the rat , 1975, Journal of neurocytology.

[42]  L. Uzych A Means to an End: The Biological Basis of Aging and Death , 2002 .